Women’s Health
Final Exams Review (Qns & Ans)
2025
1. Question: A 55-year-old postmenopausal woman with no
history of osteoporosis presents for her annual check-up. What is
the most appropriate screening test to assess her bone health?
- A) Serum Calcium
- B) Dual-energy X-ray absorptiometry (DXA) scan
- C) MRI of the lumbar spine
- D) Bone scintigraphy
ANS: B) Dual-energy X-ray absorptiometry (DXA) scan
©2025
, Rationale: DXA is the gold standard for assessing bone
mineral density in postmenopausal women and helps diagnose
osteoporosis.
2. Question: Which medication is considered first-line for the
treatment of dyslipidemia in postmenopausal women with
coronary artery disease?
- A) Aspirin
- B) Statins
- C) Beta-blockers
- D) Calcium channel blockers
ANS: B) Statins
Rationale: Statins are the primary treatment for dyslipidemia
and are proven to reduce cardiovascular events in postmenopausal
women.
3. Question: During a well-woman exam, a 30-year-old patient
asks about cervical cancer screening. How often should she
undergo a Pap smear if her previous results were normal?
- A) Annually
- B) Every 3 years
- C) Every 5 years
©2025
, - D) Every 10 years
ANS: B) Every 3 years
Rationale: For women aged 21-29 with normal results,
guidelines recommend a Pap smear every 3 years.
4. Question: What is the recommended daily intake of calcium
for a 65-year-old woman to prevent osteoporosis?
- A) 500 mg
- B) 1000 mg
- C) 1200 mg
- D) 1500 mg
ANS: C) 1200 mg
Rationale: For women older than 50, the recommended
calcium intake is 1200 mg daily to prevent osteoporosis.
5. Question: A 45-year-old woman has breast cancer with
estrogen receptor positivity. Which medication is most
appropriate for adjuvant hormonal therapy?
- A) Tamoxifen
- B) Anastrozole
©2025
, - C) Levothyroxine
- D) Metformin
ANS: B) Anastrozole
Rationale: Anastrozole, an aromatase inhibitor, is commonly
used in postmenopausal women with estrogen-receptor-positive
breast cancer.
Fill-in-the-Blank
6. Question: __________ is the most common cause of iron-
deficiency anemia in premenopausal women.
ANS: Menorrhagia
Rationale: Excessive menstrual bleeding is a principal cause
of iron-deficiency anemia in premenopausal women.
7. Question: Hormone Replacement Therapy (HRT) primarily
consists of __________ and __________ to alleviate menopausal
symptoms and reduce osteoporosis risk.
ANS: Estrogen, Progesterone
Rationale: Estrogen and progesterone are the core
components of HRT due to their effectiveness in alleviating
menopausal symptoms and protecting bone health.
©2025